North America dPCR and qPCR Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America dPCR and qPCR Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America dPCR and qPCR Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Technological Advancements in PCR Technologies Favor Market Growth

5.2 Market Opportunities

5.2.1 Rising Adoption of PCR Methods in Emerging Countries Creates Significant Opportunities in the Market

5.3 Future Trends

5.3.1 Development of Droplet Digital PCR

5.4 Impact of Drivers and Restraints

6. North America dPCR and qPCR Market Regional Analysis

6.1 North America dPCR and qPCR Market Overview

6.2 North America dPCR and qPCR Market Revenue 2020-2030 (US$ Million)

6.3 North America dPCR and qPCR Market Forecast Analysis

7. North America dPCR and qPCR Market Analysis – by Treatment

7.1 Quantitative PCR

7.1.1 Overview
7.1.2 Quantitative PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Digital PCR

7.2.1 Overview
7.2.2 Digital PCR: North America dPCR and qPCR Market – Revenue and Forecast to 2031 (US$ Million)

8. North America dPCR and qPCR Market Analysis – by Product

8.1 Reagents & Consumables

8.1.1 Overview
8.1.2 Reagents & Consumables: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Instruments

8.2.1 Overview
8.2.2 Instruments: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Software & Services

8.3.1 Overview
8.3.2 Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

9. North America dPCR and qPCR Market Analysis – by Application

9.1 Research Application

9.1.1 Overview
9.1.2 Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Clinical Application

9.2.1 Overview
9.2.2 Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Forensic Application

9.3.1 Overview
9.3.2 Software & Services: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

10. North America dPCR and qPCR Market – North America Analysis

10.1 North America

10.1.1 North America dPCR and qPCR Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America dPCR and qPCR Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America dPCR and qPCR Market Breakdown, by Treatment
10.1.1.1.2 US: North America dPCR and qPCR Market Breakdown, by Product
10.1.1.1.3 US: North America dPCR and qPCR Market Breakdown, by Application

10.1.1.2 Canada: North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America dPCR and qPCR Market Breakdown, by Treatment
10.1.1.2.2 Canada: North America dPCR and qPCR Market Breakdown, by Product
10.1.1.2.3 Canada: North America dPCR and qPCR Market Breakdown, by Application

10.1.1.3 Mexico : North America dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America dPCR and qPCR Market Breakdown, by Treatment
10.1.1.3.2 Mexico : North America dPCR and qPCR Market Breakdown, by Product
10.1.1.3.3 Mexico : North America dPCR and qPCR Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America dPCR and qPCR Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Thermo Fisher Scientific Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Takara Bio Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Qiagen NV

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Standard BioTools Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Lepu Medical Technology Beijing Co Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. Hoffmann-La Roche Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bio-Rad Laboratories Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Agilent Technologies Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights